Ikonisys SA Welcomes US Sales Director, Accelerating Its Growth and Expansion Plans in the USA

Date-01/10/2021

A organization specializing inside the early and accurate detection of cancer with a unique fully-automated answer for clinical analysis laboratories, is very thrilled to announce that diagnostic enterprise veteran, Manny Iglesias, joins as Ikonisys’ Sales Director for america marketplace. Manny’s obligations will encompass accelerating Ikoniscope20 income with the aid of strengthening Ikonisys’ presence and obtaining new customers, increasing in new geographies, and contributing to the agency’s marketing and enterprise techniques.

Manny brings over 30 years of income and leadership enjoy to Ikonisys, in the main spent inside the diagnostics sector. Manny already knows Ikonisys and the Ikoniscope properly, having been the top-selling representative at some stage in the launch of the primary-era device. Manny gained know-how developing and leading excessive-performance income teams in North and Central America at Dako, Leica Microsystems and CSI Laboratories. Additionally, he has a proficiency in process development, alternate management, automation and systems integration, advanced in the course of consulting stories with top corporations including Accenture, Schneider Electric and Johnson & Johnson. He is a graduate of the Georgia Institute of Technology and holds an MBA from the Kelley School of Business, Indiana University.

 

Ikonisys SA Welcomes US Sales Director

“Manny is an wonderful addition to our Ikonisys team, as he brings a deep blend of both human skills and technical knowledge in the diagnostics enterprise” said Jurgen Schipper, Chief Commercial Officer of Ikonisys. “As Ikonisys keeps its rapid increase and focuses throughout the US and Europe, Manny’s income leadership and full-size heritage in constructing robust customers relationships will accelerate Ikonisys’ boom.” endured Jurgen Schipper.”

“I am venerated to be part of this new development phase for Ikonisys and assist to assemble at the strong basis superior during the last years. Ikonisys is flawlessly placed to help laboratories rework their business with automation and digitalization for better diagnostic self belief and throughput, if you want to compete in the modern-day surroundings” stated Manny Iglesias, Sales Director, US.

Accelerating Its Growth and Expansion Plans in the USA Ikonisys SA

About Ikonisys 

Ikonisys SA is a cell-based totally totally diagnostics enterprise agency based in Paris (France), New Haven (Connecticut, USA) and Milan (Italy) specialized inside the early and accurate detection of most cancers. The organization develops, produces and markets the proprietary Ikoniscope20® platform, a totally-automatic answer designed to deliver accurate and dependable detection and evaluation of rare cells. Ikonisys has obtained FDA clearance for numerous automated diagnostic packages, which might be also advertised in Europe under CE certification. Through its bounce ahead fluorescence microscopy platform, the business enterprise continues to increase a move of recent exams, along with liquid biopsy assessments based totally mostly on Circulating Tumor Cells (CTC).